A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
Высоко консервативный скрытый эпитоп в рецепторсвязывающих доменах SARS-CoV-2 и SARS-CoV
2020-04-03
SCID: 54.1/22g6kzqj
Discuss with AI
CR3022 antibodySARS-CoV-2 and SARS-CoV cross-reactivitycryptic epitopereceptor binding domain
Figures from the paper
Abstract (AI)
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has now become a pandemic, but there is currently very little understanding of the antigenicity of the virus. We therefore determined the crystal structure of CR3022, a neutralizing antibody previously isolated from a convalescent SARS patient, in complex with the receptor binding domain (RBD) of the SARS-CoV-2 spike (S) protein at 3.1-angstrom resolution. CR3022 targets a highly conserved epitope, distal from the receptor binding site, that enables cross-reactive binding between SARS-CoV-2 and SARS-CoV. Structural modeling further demonstrates that the binding epitope can only be accessed by CR3022 when at least two RBDs on the trimeric S protein are in the "up" conformation and slightly rotated. These results provide molecular insights into antibody recognition of SARS-CoV-2.
Key Findings
1
CR3022 targets a highly conserved epitope on the RBD that is distal from the ACE2 receptor binding site.
2
Crystal structure of neutralizing antibody CR3022 bound to SARS-CoV-2 RBD was determined at 3.1 Å resolution.
3
Findings provide molecular insights into antibody recognition of SARS-CoV-2, informing antigenicity understanding.
4
Structural modeling shows CR3022 can access its epitope only when at least two RBDs in the trimeric spike are in the 'up' conformation and slightly rotated.
5
The conserved epitope enables cross-reactive binding between SARS-CoV-2 and SARS-CoV.
Research Object
Receptor binding domain (RBD) of the SARS-CoV-2 spike protein in complex with the neutralizing antibody CR3022
Research Subject
Structure and antigenic epitope targeted by CR3022, specifically a highly conserved cryptic epitope enabling cross-reactive binding between SARS-CoV-2 and SARS-CoV and its accessibility dependent on RBD 'up' conformations in the trimeric S protein
Publication Details
Publication Date
2020-04-03
Journal
Publisher
ISSN
Cited by
1490
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai5
Coot : model-building tools for molecular graphics2004
PHENIX : a comprehensive Python-based system for macromolecular structure solution2010
A pneumonia outbreak associated with a new coronavirus of probable bat origin2020
PHENIX: a comprehensive Python-based system for macromolecular structure solution2012
Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants2006
Cited by4
RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences2020
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-22020
Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-192020
Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates2021